Considering the effect of Notch signaling on PD1-PD-L1 axis upregulation, a more recent study revealed that a γ-secretase inhibitor (GSI) targeted the Notch pathway and exhibited strong synergistic anti-tumor effect with anti-PD1 therapy [72]. The gene discussed is CD274; the disease is neoplasm.